Results 151 to 160 of about 74,368 (309)

Immunoglobulin heavy chain-binding protein binds to misfolded mutant insulin receptors with mutations in the extracellular domain.

open access: hybrid, 1992
Domenico Accili   +5 more
openalex   +1 more source

Immunoglobulin heavy-chain status and stromal interactions shape ferroptosis sensitivity in chronic lymphocytic leukemia. [PDF]

open access: yesSignal Transduct Target Ther
Böttcher M   +16 more
europepmc   +1 more source

Translocation and rearrangement of c-myc into immunoglobulin alpha heavy chain locus in primary cells from acute lymphocytic leukemia.

open access: green, 1984
C Peschle   +9 more
openalex   +2 more sources

Clinical Impact of Immunoglobulin Heavy Chain Clonality in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. [PDF]

open access: yesCancer Med
Katai Y   +11 more
europepmc   +1 more source

Retraction Note: Trans-silencing effect of the 3'RR immunoglobulin heavy chain enhancer on Igκ transcription at the pro-B cell stage. [PDF]

open access: yesCell Mol Immunol, 2021
Ghazzaui N   +6 more
europepmc   +1 more source

Fat Mass and Obesity‐Associated Protein Contributes to Tumorigenesis and Drug Resistance of Diffuse Large B‐Cell Lymphoma by Suppressing N6‐Methyladenosine Methylation of Myc

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Ibrutinib resistance remains a major obstacle in the treatment of diffuse large B‐cell lymphoma (DLBCL). Fat mass and obesity‐associated protein (FTO) has been implicated in drug resistance through its regulation of N6‐methyladenosine (m6A) modifications; however, whether FTO mediates ibrutinib resistance in DLBCL remains unclear.
Ting‐Ting Lu   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy